Surface Oncology Inc. (SURF)
NASDAQ: SURF
· Real-Time Price · USD
1.07
-0.01 (-0.93%)
At close: Sep 07, 2023, 10:00 PM
Surface Oncology Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 14.84M | 28.98M | 50.91M | 65.1M | 74.82M | 65.66M | 56.05M | 60.85M | 83.33M | 100.53M |
Short-Term Investments | 41.42M | 73.07M | 73.91M | 81.25M | 81.82M | 84.74M | 98.1M | 88.85M | 80.94M | 70.49M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 1.59M | 1.6M | 1.69M | 1.82M | 2M | 1.98M | 1.94M | 1.98M | 2.03M |
Receivables | n/a | n/a | n/a | n/a | n/a | 30M | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | -197K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.33M | 5.15M | 4.32M | 3.77M | 4.86M | 3.89M | 3.2M | 5.06M | 6.49M | 8.03M |
Total Current Assets | 60.59M | 107.21M | 129.14M | 150.12M | 161.5M | 184.28M | 157.35M | 154.76M | 170.77M | 179.05M |
Property-Plant & Equipment | 5.42M | 28.2M | 29.17M | 29.81M | 30.65M | 31.39M | 31.52M | 31.92M | 32.77M | 33.67M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.42M | 29.8M | 30.77M | 31.5M | 32.47M | 33.4M | 33.5M | 33.85M | 34.75M | 35.7M |
Total Assets | 66.01M | 137.01M | 159.91M | 181.62M | 193.98M | 217.68M | 190.85M | 188.61M | 205.52M | 214.75M |
Account Payables | 609K | 1.11M | 256K | 535K | 486K | 2.63M | 1.55M | 440K | 1.19M | 2.32M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 9.85M | n/a | n/a | n/a |
Short-Term Debt | 9.49M | 5.81M | 5.79M | 5.76M | 8.52M | 6.41M | 5.38M | 5.44M | 8.77M | 7.17M |
Other Current Liabilities | 6.73M | 7.83M | 10.21M | 11.7M | 10.72M | 10.53M | 13.09M | 9.92M | 8.74M | 5.44M |
Total Current Liabilities | 16.83M | 14.75M | 16.26M | 17.99M | 19.73M | 19.56M | 20.02M | 15.8M | 18.7M | 14.92M |
Long-Term Debt | n/a | 46.43M | 50.25M | 50.81M | 48.54M | 51.13M | 51.92M | 41.61M | 38.73M | 40.78M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | 46.43M | 50.25M | 50.81M | 48.54M | 51.13M | 51.92M | 41.61M | 38.73M | 40.78M |
Total Liabilities | 16.83M | 61.18M | 66.51M | 68.8M | 68.26M | 70.69M | 71.95M | 57.41M | 57.43M | 55.7M |
Total Debt | 9.49M | 55.46M | 56.04M | 56.57M | 57.05M | 57.54M | 57.31M | 47.05M | 47.5M | 47.95M |
Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K |
Retained Earnings | -252.26M | -224.07M | -204.33M | -183M | -159.76M | -134.54M | -140.74M | -116.69M | -96.8M | -77.82M |
Comprehensive Income | -221K | -569K | -1.01M | -1.37M | -1.17M | -911K | -221K | -3K | -9K | -1K |
Shareholders Equity | 49.18M | 75.83M | 93.4M | 112.82M | 125.72M | 146.99M | 118.9M | 131.2M | 148.09M | 159.05M |
Total Investments | 41.42M | 73.07M | 73.91M | 81.25M | 81.82M | 84.74M | 98.1M | 88.85M | 80.94M | 70.49M |